Aktis Oncology, Inc. (AKTS) Form 8-K Material Events
Aktis Oncology, Inc. (AKTS) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AKTS
CIK: 2035832
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerSara Albano
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-24 | 2026-09-23 | 4 | 0001193125-26-401014 | View SEC Doc Filr Page |
| 144 | 2026-09-23 | — | 144 Filing | 0001950047-26-009770 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001193125-26-349144 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001193125-26-349133 | View SEC Doc Filr Page |
| 4 | 2026-07-21 | 2026-07-20 | 4 | 0001193125-26-310991 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-17 | 4 | 0001193125-26-309115 | View SEC Doc Filr Page |
| 144 | 2026-07-20 | — | 144 Filing | 0001950047-26-007234 | View SEC Doc Filr Page |
| 144 | 2026-07-17 | — | 144 Filing | 0001950047-26-007199 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | 4 | 0001193125-26-300163 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | 4 | 0001193125-26-300162 | View SEC Doc Filr Page |
| 144 | 2026-07-08 | — | 144 Filing | 0001950047-26-006961 | View SEC Doc Filr Page |
| 144 | 2026-07-08 | — | 144 Filing | 0001950047-26-006960 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-14 | — | SCHEDULE 13G Filing | 0001140361-26-021340 | View SEC Doc Filr Page |
| 10-Q | 2026-05-11 | 2026-03-31 | 10-Q | 0001193125-26-216749 | View SEC Doc Filr Page |
| 8-K | 2026-05-11 | 2026-05-11 | 8-K | 0001193125-26-216716 | View SEC Doc Filr Page |
| 4 | 2026-04-16 | 2026-04-15 | 4 | 0001193125-26-159028 | View SEC Doc Filr Page |
| 3 | 2026-04-16 | 2026-04-15 | 3 | 0001193125-26-158968 | View SEC Doc Filr Page |
| 8-K | 2026-04-16 | 2026-04-15 | 8-K | 0001193125-26-158944 | View SEC Doc Filr Page |
| 8-K | 2026-03-30 | 2026-03-30 | 8-K | 0001193125-26-132524 | View SEC Doc Filr Page |
| 10-K | 2026-03-30 | 2025-12-31 | 10-K | 0001193125-26-131748 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-01-20 | — | SCHEDULE 13D Filing | 0001231919-26-000070 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-01-20 | — | SCHEDULE 13D Filing | 0000935836-26-000046 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-01-15 | — | SCHEDULE 13D Filing | 0001193125-26-013469 | View SEC Doc Filr Page |
| 3 | 2026-01-15 | 2026-01-12 | 3 | 0001193125-26-013467 | View SEC Doc Filr Page |
| 4 | 2026-01-14 | 2026-01-12 | 4 Filing | 0001473930-26-000005 | View SEC Doc Filr Page |